Davita Inc. Stock
Davita Inc. Stock
The Davita Inc. stock is trending slightly upwards today, with an increase of €0.20 (0.130%) compared to yesterday's price.
Currently there is a rather positive sentiment for Davita Inc. with 4 Buy predictions and 1 Sell predictions.
However, we have a potential of -21.79% for Davita Inc. as the target price of 119 € is below the current price of 152.15 €.
For the coming years our community has positive and negative things to say abot the Davita Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Davita Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Davita Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Davita Inc. | 0.130% | -3.616% | -26.665% | 29.429% | 57.559% | 62.653% | 34.291% |
| Chemed Corp. | -0.440% | -3.830% | 6.103% | 17.098% | 24.176% | - | - |
| Molina Healthcare | 0.700% | -3.419% | -12.538% | 15.444% | 18.014% | -40.401% | -23.558% |
| Teladoc Health Inc | -0.740% | -2.062% | -30.808% | -9.495% | -3.472% | -73.176% | -95.090% |
Comments
DaVita (DVA) had its "buy" rating reaffirmed by Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for DVA provided by MarketBeat
DaVita (DVA) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for DVA provided by MarketBeat
DaVita (DVA) was upgraded by Zacks Research from "hold" to "strong-buy".
Show more
Ratings data for DVA provided by MarketBeat